Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis
Thyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and has shown remarkable advancements in recent years. In this study, w...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2403170 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850238864515399680 |
|---|---|
| author | Qianyu Wang Gang Pan Yu Zhang Yiqin Ni Yuzhu Mu Dingcun Luo |
| author_facet | Qianyu Wang Gang Pan Yu Zhang Yiqin Ni Yuzhu Mu Dingcun Luo |
| author_sort | Qianyu Wang |
| collection | DOAJ |
| description | Thyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and has shown remarkable advancements in recent years. In this study, we utilized visualization and bibliometric tools to analyze publications on thyroid cancer immunotherapy from the Web of Science Core Collection (WoSCC). A total of 409 articles were included, with an annual increase in both publications and citations since 2016. China leads research efforts in this area, while the University of Texas System and UTMD Anderson Cancer Center rank first in publication output. The journal Thyroid has garnered the highest citations. Notable authors contributing to this field include Antonelli Alessandro, Fallahi Poupak, and Wang Yu. Current research hotspots include immune checkpoint inhibitors, combination therapies involving immunotherapy with targeted therapy, CAR-T cell therapy, and modulation of the tumor microenvironment, all of which underscore the evolving landscape and potential for innovative treatments in thyroid cancer. |
| format | Article |
| id | doaj-art-93513f5e342d437e8a5f22a8d9910dc5 |
| institution | OA Journals |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-93513f5e342d437e8a5f22a8d9910dc52025-08-20T02:01:20ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2024.2403170Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysisQianyu Wang0Gang Pan1Yu Zhang2Yiqin Ni3Yuzhu Mu4Dingcun Luo5The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, ChinaDepartment of Oncological Surgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, ChinaDepartment of Oncological Surgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, ChinaDepartment of Oncological Surgery, Affiliated Hangzhou First People’s Hospital, School of Medicine, Westlake University, Hangzhou, ChinaThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, ChinaThe Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, ChinaThyroid cancer is a common endocrine malignancy that poses considerable therapeutic challenges in treating anaplastic carcinoma and advanced aggressive disease. Immunotherapy has become a prominent strategy for cancer treatment, and has shown remarkable advancements in recent years. In this study, we utilized visualization and bibliometric tools to analyze publications on thyroid cancer immunotherapy from the Web of Science Core Collection (WoSCC). A total of 409 articles were included, with an annual increase in both publications and citations since 2016. China leads research efforts in this area, while the University of Texas System and UTMD Anderson Cancer Center rank first in publication output. The journal Thyroid has garnered the highest citations. Notable authors contributing to this field include Antonelli Alessandro, Fallahi Poupak, and Wang Yu. Current research hotspots include immune checkpoint inhibitors, combination therapies involving immunotherapy with targeted therapy, CAR-T cell therapy, and modulation of the tumor microenvironment, all of which underscore the evolving landscape and potential for innovative treatments in thyroid cancer.https://www.tandfonline.com/doi/10.1080/21645515.2024.2403170Thyroid cancerbibliometricimmunotherapyCiteSpaceimmune checkpoint inhibitorstumor microenvironment |
| spellingShingle | Qianyu Wang Gang Pan Yu Zhang Yiqin Ni Yuzhu Mu Dingcun Luo Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis Human Vaccines & Immunotherapeutics Thyroid cancer bibliometric immunotherapy CiteSpace immune checkpoint inhibitors tumor microenvironment |
| title | Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis |
| title_full | Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis |
| title_fullStr | Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis |
| title_full_unstemmed | Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis |
| title_short | Emerging insights into thyroid cancer from immunotherapy perspective: A bibliometric analysis |
| title_sort | emerging insights into thyroid cancer from immunotherapy perspective a bibliometric analysis |
| topic | Thyroid cancer bibliometric immunotherapy CiteSpace immune checkpoint inhibitors tumor microenvironment |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2024.2403170 |
| work_keys_str_mv | AT qianyuwang emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis AT gangpan emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis AT yuzhang emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis AT yiqinni emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis AT yuzhumu emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis AT dingcunluo emerginginsightsintothyroidcancerfromimmunotherapyperspectiveabibliometricanalysis |